https://www.forbes.com/sites/nicholasreimann/2021/07/20/johnson--johnson-vaccine-far-less-effective-against-delta-variant-study-suggests/...

https://twitter.com/i/status/1412559070914093056

https://www.medpagetoday.com/special-reports/exclusives/93458

https://www.youtube.com/watch?v=agaoTSOxDCU

https://news.yahoo.com/pfizer-moderna-vaccines-effective-against-171414504.html

https://www.nytimes.com/2021/04/22/health/covid-ny-variant-vaccine.html

https://www.news-medical.net/news/20210209/Pfizer-BioNTech-COVID-19-vaccine-effective-against-variants-study-shows.aspx

Check out our work on the ACE2 microbody as a potent inhibitor of the SARS-CoV-2 virus published in Cell Reports. Congratulations and...

https://www.nature.com/naturecareers/job/postdoctoral-position-in-hiv-and-sarscov2-immune-response-and-vaccine-development-nyu-langone-me...

Congratulations Takuya!

CARISMA Therapeutics Inc. now shares the license to use the vpx lentiviral vector created in our lab to facilitate the development of...

On Monday, the lab celebrated one of our postdoc researchers, Ramajit Kaur, who was one of four recepients of the prestigious Leon Levy...

Lentiviral vector-based dendritic cell vaccine suppresses HIV replication in humanized mice Thomas D. Norton1,2*, Anjie Zhen3*, Takuya...

DESCRIPTION: Job listing on Nature Careers: https://www.nature.com/naturecareers/job?id=682759 A funded post-doctoral position is...

Dr. Nathaniel Landau appeared in the Documentary “The Battle of AmfAR”, which premiered on Dec. 2, 9pm on HBO. The documentary is...

Dr. Landau joins the TWiV team to discuss restriction of HIV replication by SAMHD1, and a viral antagonist that can be used to produce a...

Check out the article in the spring 2019 issue of the NYU Langone Health magazine. https://nyulangone.org/news/nyu-school-medicine-resea...

This week was Tom's last week in the lab. At the end of the week new and old lab members went out to dinner to celebrate Tom's time in...